These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 30728676)

  • 1. A Study on Free Light Chain Assay and Serum Immunofixation Electrophoresis for the Diagnosis of Monoclonal Gammopathies.
    Kuriakose E; Narayanan Unni Cheppayil S; Kuzhikandathil Narayanan S; Vasudevan A
    Indian J Clin Biochem; 2019 Jan; 34(1):76-81. PubMed ID: 30728676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Understanding the Constraints and Optimization of Serum Immunofixation Electrophoresis and Serum Free Light Chains for Detecting Monoclonal Proteins: A Single-Center Experience.
    Shastri M; Malhotra P; Kaur H; Aggarwal R
    J Lab Physicians; 2023 Dec; 15(4):518-523. PubMed ID: 37780881
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum free light chain assay reduces the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy.
    Fulton RB; Fernando SL
    Ann Clin Biochem; 2009 Sep; 46(Pt 5):407-12. PubMed ID: 19641008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of workflow and screening panels for the detection of malignant monoclonal gammopathies.
    Oliveros Conejero R; Pascual Usandizaga P; Garrido Chércoles A
    Adv Lab Med; 2020 Oct; 1(3):20200042. PubMed ID: 37361501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligoclonal Pattern/Abnormal Protein Bands in Post-Treatment Plasma Cell Myeloma Patients: Implications for Protein Electrophoresis and Serum Free Light Chain Assay Results.
    Singh G
    J Clin Med Res; 2017 Aug; 9(8):671-679. PubMed ID: 28725315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free light chain and intact immunoglobulin abnormalities in heart transplant recipients: Two year follow-up timelines and clinical correlations.
    Sečník P; Lavríková P; Hošková L; Malíková P; Jabor A; Franeková J
    Transpl Immunol; 2017 Mar; 41():22-26. PubMed ID: 28167270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum.
    Smith J; Raines G; Schneider HG
    Clin Chem Lab Med; 2018 Jan; 56(2):256-263. PubMed ID: 28787269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
    Böer K; Deufel T
    Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.
    Greil C; Ihorst G; Gaiser F; Salzer U; Bisse E; Kastritis E; Ludwig H; Wäsch R; Engelhardt M
    Eur J Haematol; 2017 Nov; 99(5):449-458. PubMed ID: 28886228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum-free light chain test utilisation at a South African academic laboratory and comparison with serum protein electrophoresis results.
    Banderker RB; Fazel FB; Zemlin AE; Khine AA; Jalavu TP
    Afr J Lab Med; 2023; 12(1):2201. PubMed ID: 38058849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of Clinical Decision Support to Improve the Laboratory Evaluation of Monoclonal Gammopathies.
    Pearson DS; McEvoy DS; Murali MR; Dighe AS
    Am J Clin Pathol; 2023 Feb; 159(2):192-204. PubMed ID: 36622340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum Free Light Chains in Neoplastic Monoclonal Gammopathies: Relative Under-Detection of Lambda Dominant Kappa/Lambda Ratio, and Underproduction of Free Lambda Light Chains, as Compared to Kappa Light Chains, in Patients With Neoplastic Monoclonal Gammopathies.
    Lee WS; Singh G
    J Clin Med Res; 2018 Jul; 10(7):562-569. PubMed ID: 29904440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female.
    Fager Ferrari M; Lemonakis K; Förnvik Jonsson M
    Scand J Clin Lab Invest; 2021 Sep; 81(5):385-388. PubMed ID: 34097568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum free light chains in clinical laboratory diagnostics.
    Jenner E
    Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is urine immunofixation electrophoresis necessary for monitoring myeloma patients who have undergone hematopoietic stem cell transplantation?
    Sencar ME; Yıldız A; Haznedar R
    Transfus Apher Sci; 2019 Dec; 58(6):102660. PubMed ID: 31734164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are renal reference intervals required when screening for plasma cell disorders with serum free light chains and serum protein electrophoresis?
    Abadie JM; van Hoeven KH; Wells JM
    Am J Clin Pathol; 2009 Feb; 131(2):166-71. PubMed ID: 19141376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of serum immunoglobulin free light chain assessment in patients with monoclonal gammopathies and acute renal failure.
    Cirit M; Uzüm A; Ozen P; Sentürk BA; Bozkaya G; Payzin B; Ural O
    Turk J Haematol; 2012 Dec; 29(4):385-91. PubMed ID: 24385726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Serum Free Light Chain in Diagnosis and Monitoring of Plasma Cell Disorders.
    Ansari AA; Tipu HN; Ahmed D; Farhan M
    Crit Rev Immunol; 2019; 39(3):203-210. PubMed ID: 32421964
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.